Pathology identified on imaging | Pathology identified (total cases) (n) | % with pathology present reporting PAR | % with pathology absent reporting PAR | OR (95% CI) | Fishers test (p value) |
---|---|---|---|---|---|
SAB injection (PAR n = 66) | Â | Â | Â | Â | Â |
X-ray: type 3 acromion | 4 | 75 | 33 | 6.2 (0.64, 61.23) | 0.109 |
X-ray: os acromiale | 4 | 75 | 33 | 6.1 (0.63, 60.25) | 0.112 |
X-ray: supraspinatus calcification | 16 | 56 | 31 | 2.8 (1.00, 7.97) | 0.054 |
US: supraspinatus calcification | 33 | 49 | 31 | 2.1 (1.00, 4.55) | 0.068 |
US: supraspinatus FTT | 10 | 70** | 32 | 5.0 (1.25, 20.11) | 0.033 |
ACJ injection (PAR n = 22) | Â | Â | Â | Â | Â |
X-ray: ACJ pathology | 21 | 14 | 16 | 2.1 (0.69, 6.52) | 0.189 |
US: supraspinatus tear PTT (articular surface) | 8 | 0 | 17 | 2.1 (0.39, 11.05) | 0.323 |
US: LHB tendinosis | 3 | 0 | 16 | 3.1 (0.27, 35.39) | 0.374 |
GHJ injection (PAR n = 12) | Â | Â | Â | Â | Â |
US: no rotator cuff tear | 19 | 21** | 0 | 1.3 (1.11, 1.46) | 0.029 |
US: supraspinatus tendinosis | 11 | 27 | 14 | 2.3 (0.51, 10.30) | 0.374 |
US: subscapularis tendinosis | 3 | 33 | 15 | 2.8 (0.23, 33.27) | 0.421 |
US: biceps tendon sheath effusion | 13 | 46** | 10 | 8.0 (2.02, 31.72) | 0.004 |
MRA: ACJ pathology | 46 | 20 | 11 | 2.0 (0.50, 8.23) | 0.516 |
MRA: osteolysis lateral clavicle | 5 | 40 | 15 | 3.9 (0.58, 26.58) | 0.187 |
MRA: contrast seen in SAB | 6 | 33 | 15 | 2.9 (0.47, 17.99) | 0.254 |